Reversible dementia due to vitamin B12 deficiency in a lung cancer patient: Relevance of preoperative evaluation

Cognitive dysfunction has a negative effect on cancer treatment; however, in a cancer setting, specific treatments can restore cognitive function. Such conditions are known as reversible dementia, with one of these being vitamin B12 (VB12) deficiency. However, there have been no reports of VB12 defi...

Full description

Saved in:
Bibliographic Details
Published in:Palliative & supportive care 2021-06, Vol.19 (3), p.377-379
Main Authors: Ishida, Mayumi, Taguchi, Ryo, Sakaguchi, Hirozo, Itami, Kumi, Yoshioka, Akira, Sato, Izumi, Uchida, Nozomu, Onishi, Hideki
Format: Article
Language:English
Subjects:
Anemia
Cancer therapies
Case Report
Case reports
Cognitive ability
Dementia
Lung cancer
Medical diagnosis
Older people
Oncology
Oral administration
Patients
Vitamin B
Vitamin deficiency
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cognitive dysfunction has a negative effect on cancer treatment; however, in a cancer setting, specific treatments can restore cognitive function. Such conditions are known as reversible dementia, with one of these being vitamin B12 (VB12) deficiency. However, there have been no reports of VB12 deficiency identified by preoperative evaluation in cancer patients. We studied a patient who was referred to the Department of Psycho-oncology on suspicion of cognitive decline prior to lung cancer surgery. Preoperative evaluation revealed VB12 deficiency. The patient was an 82-year-old woman diagnosed with lung cancer. She also presented with cognitive decline and, therefore, was referred to the Department of Psycho-oncology for preoperative evaluation. The patient scored 19 points on a Mini-Mental State Examination (MMSE), which is indicative of cognitive decline. As the onset of symptoms occurred several months previously and they were subacute, the possibility of reversible dementia was considered. Extensive examination revealed VB12 deficiency, and VB12 replacement therapy normalized the MMSE score to 25 points before surgery. When cognitive decline is observed in cancer patients, it is necessary to actively evaluate the serum levels of some B vitamins, including VB12.
ISSN:1478-9515
1478-9523
DOI:10.1017/S1478951521000481